Patients lacking central line access or large bore peripheral lines, experiencing hemodynamic instability, septicemia, known allergies to fresh frozen plasma, replacement colloids, albumin, or heparin, exhibiting hypocalcemia, or having recently used angiotensin-converting enzyme (ACE) inhibitors are unsuitable candidates for TPE. The gene discussed is ACE; the disease is Hypocalcemia.